PL1622632T3 - Suplementy diety na bazie owoców Acai oraz Jucara - Google Patents

Suplementy diety na bazie owoców Acai oraz Jucara

Info

Publication number
PL1622632T3
PL1622632T3 PL04758022T PL04758022T PL1622632T3 PL 1622632 T3 PL1622632 T3 PL 1622632T3 PL 04758022 T PL04758022 T PL 04758022T PL 04758022 T PL04758022 T PL 04758022T PL 1622632 T3 PL1622632 T3 PL 1622632T3
Authority
PL
Poland
Prior art keywords
fruit
jucara
dietary supplements
based dietary
acai fruit
Prior art date
Application number
PL04758022T
Other languages
English (en)
Inventor
Kenneth A Murdock
Alexander G Schauss
Original Assignee
K2A Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33510429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1622632(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by K2A Llc filed Critical K2A Llc
Publication of PL1622632T3 publication Critical patent/PL1622632T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01—Instant products; Powders; Flakes; Granules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
PL04758022T 2003-03-21 2004-03-22 Suplementy diety na bazie owoców Acai oraz Jucara PL1622632T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45688203P 2003-03-21 2003-03-21
PCT/US2004/008739 WO2004084833A2 (en) 2003-03-21 2004-03-22 Jucara and açai fruit-based dietary supplements
EP04758022A EP1622632B1 (en) 2003-03-21 2004-03-22 Jucara and acai fruit-based dietary supplements

Publications (1)

Publication Number Publication Date
PL1622632T3 true PL1622632T3 (pl) 2012-10-31

Family

ID=33510429

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04758022T PL1622632T3 (pl) 2003-03-21 2004-03-22 Suplementy diety na bazie owoców Acai oraz Jucara

Country Status (12)

Country Link
US (9) US7563465B2 (pl)
EP (1) EP1622632B1 (pl)
JP (1) JP2006520804A (pl)
KR (1) KR101166928B1 (pl)
CN (2) CN101238895B (pl)
AT (1) ATE549027T1 (pl)
AU (1) AU2004224346B2 (pl)
BR (1) BRPI0408589A (pl)
CA (1) CA2529584C (pl)
ES (1) ES2387121T3 (pl)
PL (1) PL1622632T3 (pl)
WO (1) WO2004084833A2 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563465B2 (en) * 2003-03-21 2009-07-21 K2A Llc Jucara and Açai fruit-based dietary supplements
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
MY162337A (en) 2005-05-02 2017-06-15 4Life Res Llc Transfer factor preparations and associated methods
RU2008110039A (ru) * 2005-08-15 2009-09-27 Юнилевер Н.В. (Nl) Соломинка для питья
EP1981513B1 (en) 2006-01-19 2015-05-27 Mary Kay, Inc. Compositions comprising kakadu plum extract or acai berry extract
UA92784C2 (ru) * 2006-01-19 2010-12-10 Мэри Кей, Инк. Композиции, которые содержат фруктовый экстракт, выбранный из экстракта сливы какаду или экстракта ягоды акаи
BRPI0604281A (pt) 2006-07-18 2008-03-04 Roberto Soares De Moura processo para obtenção de decotos de frutos e caroços de euterpe oleracea (açaì) processo de obtenção de extratos hidro-alcoólicos a partir dos decotos; processo obtenção de liofilizado e/ou spray dryer do extrato hidro-alcoólico; composições farmacêuticas contendo os liofilizados e/ou spray dryer dos ditos extratos e uso terapêutico das composições como vasodilatador no tratamento das sìndromes isquêmicas, vaso-espásticas e da hipertenção arterial
FR2910815B1 (fr) * 2006-12-28 2010-10-29 Expanscience Lab Composition comprenant un extrait de graines de quinoa
WO2008156627A1 (en) * 2007-06-15 2008-12-24 The Texas A & M University System Phytochemical-rich oils and methods related thereto
TWI519307B (zh) * 2007-10-24 2016-02-01 Suntory Holdings Ltd The ligand of peroxisome proliferator activated receptor (PPAR)
JP2009256326A (ja) * 2008-03-21 2009-11-05 Kose Corp 美白剤、及び皮膚外用剤
US20090246344A1 (en) * 2008-03-31 2009-10-01 Sasaki Tea Manufacturing Co., Ltd. Antioxidant Agent and Beverage Using Same
KR101682512B1 (ko) * 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
US9176146B2 (en) * 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
US9050275B2 (en) * 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
WO2011026202A1 (pt) * 2009-09-03 2011-03-10 Universidade Do Estado Do Rio De Janeiro - Uerj Processo de obtenção de produtos de tabaco contendo substâncias antioxidantes e produto obtido
US8932468B2 (en) * 2010-01-12 2015-01-13 The United States Of America As Represented By The Secretary Of The Army Separation of enzymatically synthesized polyepicatechin via high performance liquid chromatography
BRPI1003215A2 (pt) * 2010-02-23 2012-03-20 Universidade Do Estado Do Rio De Janeiro - Uerj Processo para preparação de pomadas, contendo antioxidantes obitdos de plantas ricas em polifenóis, para utilização no tratamento de feridas de diversas etiologias nas quais existe um aumento de fatores pró-oxidantes e/ou grande formação de espécies reativas derivadas do oxigênio e/ou menor formação de óxido nítrico
PH12012501787A1 (en) 2010-03-15 2012-12-10 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
JP5818410B2 (ja) * 2010-08-03 2015-11-18 長谷川香料株式会社 食品にオラック値を付与する香料組成物
BRPI1003060B1 (pt) 2010-08-04 2017-03-07 Amazon Dreams Indústria E Comércio S A processo de obtenção de extratos parcialmente purificados de compostos antioxidantes de frutos de palmeiras do gênero euterpe
US20120121763A1 (en) * 2010-11-12 2012-05-17 Marni Markell Hurwitz Pulp food product, process and method of manufacturing same
JP5821259B2 (ja) 2011-04-22 2015-11-24 セイコーエプソン株式会社 画像表示システム、画像表示装置、３ｄメガネ、及び、画像表示方法
WO2013013371A1 (en) * 2011-07-22 2013-01-31 Nestec S.A. Dried pulp preparation from unprocessed raw materials
KR101317738B1 (ko) * 2012-03-30 2013-10-15 이상호 가축 성장촉진용 첨가제 및 그 제조방법
JP6072545B2 (ja) * 2013-01-18 2017-02-01 株式会社ミルボン 非水系毛髪化粧料
CN103736085B (zh) * 2013-12-27 2015-07-29 南宁市品迪生物工程有限公司 一种预防和治疗老年性痴呆的药物
US20210128567A1 (en) 2017-08-29 2021-05-06 Flaask, Llc Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder
WO2019075456A2 (en) 2017-10-13 2019-04-18 Locus Ip Company, Llc METHODS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES
MY194335A (en) * 2018-03-08 2022-11-29 Malaysian Palm Oil Board Composition for delaying ageing process and increasing longevity in a subject and methods thereof
WO2021243351A2 (en) * 2020-05-26 2021-12-02 Mars, Incorporated Process for preparing pet food and pet food obtainable thereby
CN114009755A (zh) * 2021-09-29 2022-02-08 黑龙江飞鹤乳业有限公司 阿萨伊的发酵方法及发酵产物
US12003178B2 (en) 2021-11-12 2024-06-04 Diodes Incorporated Adaptive minimum duty cycle design to extend operational voltage range for DCDC converters

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920815A (en) * 1970-04-15 1975-11-18 Mirlin Corp Taste-modifying composition
JPH06271850A (ja) * 1993-03-23 1994-09-27 Nikken Food Kk 天然物を原料とした抗酸化剤およびその製造方法
US6231866B1 (en) * 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
CN1269421C (zh) * 1998-12-11 2006-08-16 密执安州大学 生产源于浆果的产物的方法和组合物
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP2001046030A (ja) * 1999-08-02 2001-02-20 Tama Seikagaku Kk ブルーベリー抽出エキスの製造法
KR20060123663A (ko) * 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유하는 조성물
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US7014873B2 (en) * 2001-11-14 2006-03-21 Morinda, Inc. Method and formulation for treating candidiasis using morinda citrifolia
US7182935B2 (en) * 2002-06-19 2007-02-27 Empresa Brasileira De Pesquisa Agropecuaria Embrapa Bacterial plaque evidencing composition based on natural colorants
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
US7563465B2 (en) * 2003-03-21 2009-07-21 K2A Llc Jucara and Açai fruit-based dietary supplements
US7232585B2 (en) * 2004-06-24 2007-06-19 Xel Herbaceuticals, Inc. Green tea formulations and methods of preparation
US20080050498A1 (en) * 2004-10-07 2008-02-28 Next Proteins, Inc. Powdered protein beverage mix and methods of making the same
WO2006055550A2 (en) * 2004-11-15 2006-05-26 Borba, Llc Nutritional beverage with skin improvement aids
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
MY162337A (en) * 2005-05-02 2017-06-15 4Life Res Llc Transfer factor preparations and associated methods
US20070196298A1 (en) * 2005-05-31 2007-08-23 Kostick Richard H Cosmetic and dermatological formulations with natural pigments and methods of use
US20070166253A1 (en) * 2005-05-31 2007-07-19 Velveteen Bunni Llc Cosmetic and dermatological formulations with natural pigments
US20070065396A1 (en) * 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
US8962058B2 (en) * 2005-11-23 2015-02-24 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
EP1981513B1 (en) * 2006-01-19 2015-05-27 Mary Kay, Inc. Compositions comprising kakadu plum extract or acai berry extract
US20090196921A1 (en) * 2008-02-06 2009-08-06 The Procter & Gamble Company Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition

Also Published As

Publication number Publication date
KR101166928B1 (ko) 2012-08-16
CA2529584A1 (en) 2004-10-07
US20090156513A1 (en) 2009-06-18
BRPI0408589A (pt) 2006-03-21
EP1622632A2 (en) 2006-02-08
WO2004084833A8 (en) 2007-06-21
US9352009B2 (en) 2016-05-31
US20060275511A1 (en) 2006-12-07
KR20060002838A (ko) 2006-01-09
CN101238895A (zh) 2008-08-13
CN101238895B (zh) 2011-04-13
US20130095195A1 (en) 2013-04-18
US20150258163A1 (en) 2015-09-17
US8153170B2 (en) 2012-04-10
US20100003355A1 (en) 2010-01-07
EP1622632A4 (en) 2009-09-02
US20090148390A1 (en) 2009-06-11
AU2004224346B2 (en) 2009-11-12
WO2004084833A3 (en) 2005-01-20
ATE549027T1 (de) 2012-03-15
WO2004084833A2 (en) 2004-10-07
US7799354B2 (en) 2010-09-21
US9526755B2 (en) 2016-12-27
EP1622632B1 (en) 2012-03-14
CN1791418A (zh) 2006-06-21
ES2387121T3 (es) 2012-09-14
US20090155398A1 (en) 2009-06-18
US7700138B2 (en) 2010-04-20
CN1791418B (zh) 2012-03-07
US7563465B2 (en) 2009-07-21
US20100239694A1 (en) 2010-09-23
US7727564B2 (en) 2010-06-01
CA2529584C (en) 2014-05-27
JP2006520804A (ja) 2006-09-14
AU2004224346A1 (en) 2004-10-07
US9066975B2 (en) 2015-06-30
US20150258164A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
EP1622632A4 (en) FOOD SUPPLEMENT BASED ON JUCARA AND ACAI FRUITS
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
WO2007076416A3 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
WO2009013596A3 (en) Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products
MY150500A (en) Stable nutritional powder
WO2005065669A8 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
MX2008014265A (es) Composiciones lipidas estructuradas y metodos para su fabricacion.
WO2008066380A3 (en) Process for the preparation of powdered oils
MY157678A (en) Freeze-dried,aerated fruit or vegetables compositions and methods of making thereof
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
WO2008031798A3 (en) Edible wafer products produced by extrusion
IL164089A0 (en) Astaxanthin medium-chain fatty acidester, production method of the same, and composition comprising the same
WO2008145247A3 (de) Antioxidationsmittel für lebensmittel
WO2003101923A3 (en) Policosanol compositions, extraction from novel sources, and uses thereof
UA94238C2 (ru) Волокна цитрусового фрукта в эмульсиях
WO2002056708A3 (de) Zubereitung zur verbesserung der nahrungsverwertung
WO2006069668A8 (de) Verfahren zur herstellung eines rohöls aus gemischen von mikroorganismen und pflanzen, das so hergestellte öl sowie die spezifischen verwendungen des so hergestellten und gegebenenfalls zusätzlich raffinierten öls
WO2009126389A3 (en) Fruit or vegetable and grain snack mixture
PL1876906T3 (pl) Suplement diety lub żywność funkcjonalna zawierające mieszaninę olejów
UA94230C2 (ru) Композиция, которая содержит волокна цитрусовых фруктов, и ее применение в производстве мясных продуктов
WO2006107820A3 (en) Lignan-containing compositions
TW200510364A (en) Flavanone compound and uses thereof
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
WO2004000043A3 (en) Nutraceutic compositions and food supplements containing nadh
WO2009100547A3 (en) Pet food product and method for its manufacture